On June 27, Gelunhui reported that Wuhan Hvsen Biotechnology (300871.SZ) received a notice from the company's board secretary Wang Qingfeng on June 27, 2024. Based on his confidence in the company's future development prospects and the recognition of the long-term investment value of the company's stocks and derivatives, Wang Qingfeng used his own funds on June 27, 2024 to increase his shareholding of the company's convertible bonds in the secondary market through the Shenzhen Stock Exchange trading system. The number of bonds increased by 10,040, and the transaction price of each bond was 99.56 yuan.
回盛生物(300871.SZ)：董事会秘书王庆峰增持1.004万张可转换公司债券
Wuhan Hvsen Biotechnology (300871.SZ): Board of Directors Secretary Wang Qingfeng increased his shareholding of 10,040 convertible corporate bonds.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.